BeiGene Profit Margin 2014-2024 | ONC
Current and historical gross margin, operating margin and net profit margin for BeiGene (ONC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. BeiGene net profit margin as of September 30, 2024 is -25.94%.
| BeiGene Annual Profit Margins |
| BeiGene Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$17.962B |
$2.459B |
|
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
|
